#immunotherapy

#immunotherapy

Allergy shots can offer long-lasting relief for certain allergies but involve time, discomfort, and cost that need to be considered.

Teddi Mellencamp faces a serious cancer battle with a 50/50 survival prognosis but remains hopeful and focuses on positivity.

Early detection and testing for lymphoma can lead to better outcomes.

Emotional support is crucial for those suffering from illness.

Immunotherapy represents a revolutionary advancement in cancer treatment, surpassing traditional methods like chemotherapy and radiotherapy in efficacy.

Cancer treatment has evolved from limited options to advanced personalized therapies.

Investment in new technologies has transformed cancer care significantly.

Challenges remain in equitable distribution of effective cancer treatments.

A woman has remained cancer-free for over 18 years following CAR T-cell therapy for neuroblastoma, showing promise for solid tumor treatments.

Immunotherapy like Libtayo can significantly improve cancer treatment outcomes, even in complex cases.

Scientists can trick the immune system into attacking disguised tumours to potentially treat cancer.

The new technique requires more clinical testing to verify its true efficacy.

B-cell therapy may offer a new, promising approach to treating glioblastoma.

CAR T-cell therapy has shown groundbreaking success, particularly for a girl with nerve-cell cancer who is now cancer-free after 19 years.

Dostarlimab immunotherapy shows promise for treating solid tumors with fewer severe side effects, achieving remarkable tumor regression in clinical trials.

The world's first mRNA lung cancer vaccine, BNT116, shows promise in treating non-small cell lung cancer and improving survival rates.

HERVolution secures $11.7 million Series A funding to advance HERV-targeting immunotherapies.

Lumicks has secured €20mn funding to enhance immunotherapy drug discovery by improving its real-time cell avidity analyser technology.

Citryll has raised €85M in Series B funding for its innovative therapy targeting Neutrophil Extracellular Traps (NETs) in inflammatory diseases.

Immunotherapy has significantly improved prognosis and survival rates for patients with metastatic melanoma over the past 15 years.

AI algorithms are aiding oncologists in predicting responders to immunotherapy, improving treatment outcomes.

CAR-T-cell therapy faces FDA investigation for potential link to lymphomas.

CAR-T cell therapy revolutionizes blood cancer treatment by enhancing T-lymphocytes to combat tumors, with potential for wider application beyond hematological cancers.